Japan Sexual Dysfunction Treatment Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the Japan Sexual Dysfunction Treatment Market was valued at USD 621 Million in 2025 and is projected to reach USD 1,028 Million by 2032, growing at a CAGR of approximately 7.5% during 2026–2032.
Japan Sexual Dysfunction Treatment Market Highlights
| Report Metric | Details |
| Report Name | Japan Sexual Dysfunction Treatment Market (2026-2032) |
| Market Size 2025 | USD 621 Million |
| Market Size 2032 | USD 1,028 Million |
| Absolute Growth 2025–2032 | USD 407 Million |
| CAGR 2026–2032 | 7.5% |
| Peak Annual Growth | 8.5% in 2029 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Treatment Type, 2025 | PDE5 Inhibitors (52% share) |
| Leading Gender Focus, 2025 | Male (45% share) |
| Leading Administration Mode, 2025 | Oral (46% share) |
| Leading End User, 2025 | Clinics & Pharmacies (49% share) |
| Fastest-Growing Treatment Type | Hormone Replacement Therapy (10.7% CAGR) |
| Fastest-Growing Gender Focus | Female (9.8% CAGR) |
| Fastest-Growing Administration Mode | Transdermal/Injectable (11.1% CAGR) |
| Fastest-Growing End User | Hormonal Therapy Centers (10.1% CAGR) |
| Growing Sector | Sexual health services |
| Key End Users | Clinics, Pharmacies, Hormonal Therapy Centers, Urologists |
Japan Sexual Dysfunction Treatment Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Each row of the following table gives one year's estimated growth and the event or demand shift that explains it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.2 | The market showed steady demand with approximately 3 million men reporting erectile dysfunction. |
| 2023 | 4.1 | Growth slowed slightly as awareness programs for sexual health gained traction. |
| 2024 | 3.4 | The market continued to grow, supported by rising prescriptions for hormone replacement therapy. |
| 2025 | 4.0 | Demand increased as more patients sought treatment for sexual dysfunction. |
| 2026 | 6.5 | Growth accelerated due to the introduction of new treatment guidelines by the Japanese Urological Association. |
| 2027 | 7.1 | The market expanded further as online therapy platforms gained popularity among users. |
| 2028 | 7.2 | Demand continued to rise, driven by increased awareness of sexual health issues. |
| 2029 | 8.5 | The market peaked as PDE5 inhibitors remained the most prescribed treatment option. |
| 2030 | 7.7 | Growth slowed slightly as competition among treatment options intensified. |
| 2031 | 7.0 | The market continued to grow, supported by ongoing awareness initiatives and education. |
| 2032 | 8.3 | Demand surged as hormone replacement therapy gained acceptance among older men. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
Japan Sexual Dysfunction Treatment Market Synopsis
Sexual Dysfunction Treatment encompasses pharmacological and therapeutic interventions designed to address erectile dysfunction and hormonal imbalances. Market growth stems from heightened consumer awareness and an increasing number of clinics providing specialised services. In 2022, around 3 million men reported experiencing erectile dysfunction, and new guidelines from the Japanese Urological Association are likely to further stimulate demand. The Tokyo metropolitan area, characterised by a high density of clinics, serves as a major source of demand for these treatments.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increased awareness of sexual health issues | Driver | High | PDE5 Inhibitors |
| Rising prescriptions for hormone replacement therapy | Driver | High | Hormone Replacement Therapy |
| Growing demand for online therapy platforms | Opportunity | Medium | Counseling & Therapy |
| Expansion of specialized clinics for hormone therapy | Opportunity | Medium | Hormonal Therapy Centers |
| Limited access to specialized healthcare providers in rural areas | Restraint | High | Clinics & Pharmacies |
| High cost of PDE5 inhibitors affecting affordability | Restraint | Medium | PDE5 Inhibitors |
| Competition from alternative treatment options | Challenge | High | Hormone Replacement Therapy |
| Regulatory hurdles for new treatment approvals | Challenge | Medium | Counseling & Therapy |
Evaluation of Drivers in Japan Sexual Dysfunction Treatment Market (2026–2032)
Demand rests on the following drivers, each shown with the segment it touches most.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Growing number of clinics offering sexual dysfunction treatments | PDE5 Inhibitors | The Tokyo metropolitan area has the highest concentration of clinics, leading to increased patient access and prescriptions, with over 2,000 pharmacies offering related products. |
| Rising awareness of hormonal imbalances among older men | Hormone Replacement Therapy | Hormone Replacement Therapy is increasingly prescribed for men over 40, driving demand for treatments as awareness of low testosterone levels rises. |
| Increase in online consultations for sexual health | Counseling & Therapy | Online therapy platforms have seen a 25% increase in usage, making consultations more accessible for patients seeking help. |
| Support from professional associations for sexual health education | Clinics & Pharmacies | The Japan Society of Sexual Medicine advocates for improved access to sexual health services, promoting awareness among the public. |
| Growing acceptance of sexual health treatments among the public | Device-Based Solutions | Awareness programs funded by the Ministry of Health, Labour and Welfare are promoting sexual health, increasing acceptance of various treatments. |
Buyers are expanding their options as the number of clinics offering sexual dysfunction treatments rises, particularly in urban centres where access is most convenient. In 2022, around 3 million men reported experiencing erectile dysfunction, resulting in a surge in prescriptions for PDE5 inhibitors. The growing awareness of hormonal imbalances among older men is propelling demand for hormone replacement therapies. The rise of online consultations for sexual health has improved accessibility, enabling patients to seek assistance without fear of stigma. Support from professional associations for sexual health education is increasing public awareness and acceptance of these treatments, further driving market growth.
Evaluation of Restraints in Japan Sexual Dysfunction Treatment Market
Several factors work against faster growth; the main ones are summarised below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Competition from alternative treatment options | Device-Based Solutions | Emerging therapies may divert patients away from traditional treatment methods, impacting market share. In 2023, new treatment options were introduced, creating more choices for patients. |
| Limited access to specialized healthcare providers in rural areas | Counseling & Therapy | Patients in rural regions face challenges in finding qualified professionals, leading to delays in treatment. Approximately 30% of the population lives in these areas, limiting access. |
| High costs of treatment options | Hormone Replacement Therapy | The average cost of hormone therapy can be prohibitive for many patients, with prices exceeding 1,500 yen per dose, affecting affordability. |
| Regulatory complexities in treatment approval | PDE5 Inhibitors | The stringent oversight by the Japanese Pharmaceutical Association can delay the introduction of new treatments, limiting options for patients. |
| Stigma surrounding sexual health issues | PDE5 Inhibitors | Cultural attitudes towards sexual health can deter individuals from seeking treatment, impacting overall market growth. |
Japan Sexual Dysfunction Treatment Market Challenges
Around 3 million men in Japan reported experiencing erectile dysfunction, which raises treatment costs for patients. Buyers encounter high prices, with PDE5 inhibitors averaging about 1,500 yen per dose, putting pressure on the budgets of those with limited incomes. Regulatory complexities arise from the Japanese Pharmaceutical Association's stringent oversight, causing delays in the introduction of new therapies for suppliers and limiting options for patients. A shortage of skilled professionals in sexual health results in longer wait times for consultations in urban areas, often exceeding two weeks for many buyers.
Trends in the Japan Sexual Dysfunction Treatment Market
The trends below show where the Japan Sexual Dysfunction Treatment Market is heading.
- Shift towards Online Therapy Platforms: Tokyo is experiencing a shift towards online therapy platforms for sexual health consultations, with a 25% increase in usage in 2023. This trend improves accessibility for patients seeking help.
- Rising Popularity of Hormone Replacement Therapy: In 2023, Hormone Replacement Therapy is gaining traction among men over 40, with increasing prescriptions noted. This shift reflects a growing recognition of hormonal imbalances affecting quality of life.
- Increased Focus on Sexual Health Education: The Ministry of Health, Labour and Welfare's funding of 200 million yen for sexual health education initiatives is transforming public awareness. This investment is vital for improving treatment uptake and reducing stigma.
- Emergence of Wearable Health Devices: Research institutions are developing wearable devices for monitoring sexual health, indicating a technological shift. These innovations could improve patient engagement and treatment effectiveness.
Investment Opportunities in the Japan Sexual Dysfunction Treatment Market
The following opportunities in the Japan Sexual Dysfunction Treatment Market pair current demand with a clear way in.
- Investment in Online Therapy Platforms: The rise of online therapy platforms presents an opportunity to invest in digital health solutions, especially with usage increasing by 25% in 2023. Collaborating with mental health facilities can expand service offerings.
- Expansion of Hormonal Therapy Centers: With the growing demand for hormone replacement therapy, establishing specialised centres can address patient needs. The Tokyo region is particularly well-suited for such facilities, attracting more patients seeking treatment.
- Development of Wearable Health Devices: Investing in the development of wearable devices for sexual health monitoring is timely, given the rising interest in technology. Partnering with research institutions can drive innovation in this area.
- Improving Access to Sexual Health Education: There is a notable opportunity to provide educational resources on sexual health, particularly with 200 million yen allocated for initiatives. Collaborating with healthcare providers can enhance outreach and awareness.
Government Initiatives in the Japan Sexual Dysfunction Treatment Market
The Medical Care Act of 1948 sets standards for hospitals and clinics, ensuring that facilities meet necessary requirements for treating sexual dysfunction. Recent amendments to this law improve the quality of care and access to treatments for patients experiencing sexual health issues. Additionally, the Next-Generation Medical Infrastructure Act allows certified organisations to anonymise medical data for research, which aids in developing new treatments for sexual dysfunction.
The Japanese Pharmaceutical Association oversees the regulation of sexual dysfunction medications, ensuring safety and efficacy. This agency also approves new treatments, facilitating timely access for patients while maintaining stringent safety standards.
Future Insight of the Japan Sexual Dysfunction Treatment Market
New specialised clinics focused on sexual dysfunction treatment will emerge by 2032, improving access for buyers. Increased integration of online therapy platforms will offer greater convenience for consultations, reflecting a shift towards digital solutions. The government's 200 million yen investment in sexual health education initiatives will raise awareness and encourage more individuals to seek treatment. Advancements in wearable devices for monitoring sexual conditions will empower patients to manage their wellbeing more effectively.
Market Segmentation Analysis
Japan Sexual Dysfunction Treatment Market report covers a detailed analysis of the following market segments:
By Treatment Type – PDE5 Inhibitors Lead, Hormone Replacement Therapy Expected to Grow Fastest
According to Saurav Kr Singh, Senior Research Analyst at 6Wresearch, with 52% of treatment type revenue in 2025, PDE5 Inhibitors was the largest category. PDE5 inhibitors dominate the market due to their widespread prescription for erectile dysfunction, addressing the needs of approximately 3 million men in Japan. Their established efficacy and the backing of clinical guidelines contribute to their strong market presence. The quickest growth will come from Hormone Replacement Therapy, forecast to expand at a CAGR of 10.7% between 2026 and 2032. Hormone Replacement Therapy is experiencing rapid growth as awareness increases among men over 40 facing low testosterone levels, with a notable rise in prescriptions. This trend is supported by new guidelines from the Japanese Urological Association, further driving demand. Suppliers should focus on expanding their offerings in hormone therapies to capture the growing market.
By Gender Focus – Male Leads, Female Expected to Grow Fastest
Male took 45% of gender focus revenue in 2025, more than any other category. The male segment leads the market as treatments predominantly address erectile dysfunction, which affects around 3 million men in Japan. This is reflected in the extensive network of clinics and pharmacies that primarily serve male patients' needs. Over 2026–2032, Female is expected to post the fastest growth, at a CAGR of 9.8%. The female segment is witnessing swift growth due to increasing recognition of female sexual dysfunction, resulting in more customised treatment options. This trend is supported by the Japan Society of Obstetrics and Gynecology, which has established new standards for female sexual health treatments. Providers must adjust their offerings to include female-focused treatments to effectively engage this expanding market.
By Administration Mode – Oral Leads, Transdermal/Injectable Expected to Grow Fastest
Oral held 46% of the Japan Sexual Dysfunction Treatment Market by administration mode in 2025. Oral administration is the predominant method for sexual dysfunction medications, valued for its convenience and simplicity for patients. The significant market share of PDE5 inhibitors, which are mainly available in oral form, underscores this preference. Transdermal/Injectable is set to record the highest CAGR in this split, 11.1% over 2026–2032. Transdermal and injectable methods are gaining traction as they offer alternative delivery options for specific therapies, appealing to patients who prefer varied treatment experiences. The rising popularity of transdermal patches for hormone therapy exemplifies this shift. Suppliers should broaden their product lines to include transdermal and injectable options to meet evolving patient preferences.
By End User – Clinics & Pharmacies Lead, Hormonal Therapy Centers Expected to Grow Fastest
The largest end user category in 2025 was Clinics & Pharmacies, at 49% of revenue. Clinics and pharmacies serve as the main access points for sexual dysfunction treatments, essential for patient care and medication distribution. Their widespread presence, especially in urban regions, ensures prompt consultations and access to necessary therapies. Hormonal Therapy Centers are projected to grow fastest, at a CAGR of 10.1% during 2026–2032. Hormonal Therapy Centers are expanding rapidly as specialised facilities focusing on hormone-related issues, reflecting a growing demand for targeted treatments. Increased awareness initiatives by health authorities further facilitate this growth. Suppliers should enhance partnerships with hormonal therapy centres to optimise distribution and service delivery.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Japan Sexual Dysfunction Treatment Market Outlook
- Market Size of Japan Sexual Dysfunction Treatment Market, 2025
- Forecast of Japan Sexual Dysfunction Treatment Market, 2032
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Revenues & Volume for the Period 2022-2032F
- Japan Sexual Dysfunction Treatment Market Trend Evolution
- Japan Sexual Dysfunction Treatment Market Drivers and Challenges
- Japan Sexual Dysfunction Treatment Price Trends
- Japan Sexual Dysfunction Treatment Porter's Five Forces
- Japan Sexual Dysfunction Treatment Industry Life Cycle
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Treatment Type for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By PDE5 Inhibitors for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Hormone Replacement Therapy for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Counseling & Therapy for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Device-Based Solutions for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Gender Focus for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Male for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Female for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Both for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Both for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Administration Mode for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Oral for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Transdermal/Injectable for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By In-Person/Online for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Wearable/Implantable for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By End User for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Clinics & Pharmacies for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Hormonal Therapy Centers for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Mental Health Facilities for the Period 2022-2032F
- Historical Data and Forecast of Japan Sexual Dysfunction Treatment Market Revenues & Volume By Urologists & Gynecologists for the Period 2022-2032F
- Japan Sexual Dysfunction Treatment Import Export Trade Statistics
- Market Opportunity Assessment By Treatment Type
- Market Opportunity Assessment By Gender Focus
- Market Opportunity Assessment By Administration Mode
- Market Opportunity Assessment By End User
- Japan Sexual Dysfunction Treatment Top Companies Market Share
- Japan Sexual Dysfunction Treatment Competitive Benchmarking By Technical and Operational Parameters
- Japan Sexual Dysfunction Treatment Company Profiles
- Japan Sexual Dysfunction Treatment Key Strategic Recommendations
Market Covered
The report covers the following segments.
By Treatment Type
- PDE5 Inhibitors
- Hormone Replacement Therapy
- Counseling & Therapy
- Device-Based Solutions
By Gender Focus
- Male
- Female
- Both
By Administration Mode
- Oral
- Transdermal/Injectable
- In-Person/Online
- Wearable/Implantable
By End User
- Clinics & Pharmacies
- Hormonal Therapy Centers
- Mental Health Facilities
- Urologists & Gynecologists







